Background. Vertebral fractures are one of the severe complications of systemic osteoporosis, which lead to the low-back pain, decrease or loss of efficiency and increase of mortality in older people. FRAX and dual-energy X-ray absorptiometry (DXA) are important methods in determining major osteoporotic fractures risk, including vertebral fractures. Materials and methods. We studied the parameters of Ukrainian model of FRAX in women depending on the presence of vertebral fractures. 652 patients aged 40–89 years examined at the Ukrainian Scientific Medical Center of Osteoporosis were divided into two groups: the first one — 523 women without any previous fractures, the second one — 129 patients with previous vertebral fractures. The assessment of bone mineral density (BMD) was performed using DXA (Prodigy, General Electric). The 10-year probability of major osteoporotic fractures (FRAX-MOF) and hip fractures (FRAX-HF) has been determined using Ukrainian model of FRAX according to two methods — with body mass index (FRAXBMI) and BMD. Results. According the distribution of FRAXBMI-MOF parameters in women depending on the presence of vertebral fractures, it was found that index of FRAXBMI-MOF was less than 20 % (the limit indicated as the criterion for treatment initiation in US guidelines) in 100 and 100 % of subjects, respectively. The indices of FRAX BMD-HF were less than 3 % (the limit for starting treatment in US guidelines) in 95 and 55 % of women, respectively. It was shown the significant moderate correlation between the indices of two methods in all groups for both parameters of the algorithm — FRAX-MOF and FRAX-HF. Conclusions. The study of the age-specific features of FRAX in women depending on the presence of vertebral fractures showed a significant increase in the risks for both major osteoporotic and hip fractures, regardless of the used technique (with BMI or BMD) in women with vertebral fractures or without any fractures. Our results should be taken into account when assessing the risk of osteoporotic fractures in postmenopausal women and planning treatment and prophylactic measures.

osteoporosis; vertebral fractures; FRAX; X-ray densitometry

Povoroznуuk VV, Grуgorieva NV, Orlyk TV, et al. Osteoporoz v praktike vracha-internista [Osteoporosis in the practice of the internist]. Кiyv; 2014. 198p.

Kanis JA on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2007: Printed by the University of Sheffield.

Kanis JA, Oden A, Johnell O. Et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033-46. doi: 10.1007/s00198-007-0343-y.

McCloskey EV, Harvey NC, Johansson H, Kanis JA. FRAX updates 2016. Curr Opin Rheumatol. 2016 Jul;28(4):433-41. doi: 10.1097/BOR.0000000000000304.

Kanis JA, Harvey NC, Cooper C, et al. A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group andthe International Osteoporosis Foundation. Arch Osteoporos.-2016.-11(1).-Р. 25. doi: 10.1007/s11657-016-0278-z. Arch Osteoporos. 2016 Dec;11(1):25. doi: 10.1007/s11657-016-0278-z.

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis – 2016-Executive Summary. Endocr Pract. 2016 Sep;22(9):1111-8. doi: 10.4158/EP161435.ESGL.

Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y.

Cauley JA, El-Hajj Fuleihan G, Arabi A, et al. Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom. 2011 Jul-Sep;14(3):240-62. doi: 10.1016/j.jocd.2011.05.015.

Povoroznуuk VV, Grуgorieva NV. The role of FRAX in predicting fracture risk. Novosti Meditsiny i Farmatsii. 2011;16(379). (in Russian)

Povoroznуuk VV, Grуgorieva NV. Information Value of Different Models of FRAX in Assessing the Risk of Osteoporotic Fractures in Women of Ukraine. Bol', Sustavy, Pozvonochnik. 2013;2(10):32-41. (in Russian)

Povoroznуuk VV, Grуgorieva NV. Evaluation the Potential of the Austrian FRAX Model Use in Predicting the Risk for Osteoporotic Fractures in Ukrainian Women. Bol', Sustavy, Pozvonochnik. 2013;3(11):13-20. (in Russian)

Povoroznyuk VV, Grygorieva NV, Kanis JA, McCloskey EV, Johansson H, Korzh MO, Strafun SS, Vaida VM, Klymovytsky FV, Vlasenko RO, Forosenko VS. Epidemiology of osteoporotic fractures in Ukraine: results of two retrospective studies. Osteoporos int. 2017; Ahead of print.

Povoroznyuk VV, Grygorieva NV, Kanis JA, et al. Epidemiology of hip fracture and the development of FRAX in Ukraine. Arch Osteoporos. 2017;12(1):53. doi:10.1007/s11657-017-0343-2. 

Povoroznyuk VV, Grygorieva NV, Korzh MO, et al. Epidemiology of proximal femur fractures in Ukraine: results of two retrospective studies. Ortopediia, travmatologiia i protezirovanie. 2016;4:68-74. doi: 10.15674/0030-59872016468-74. (in Ukrainian)

Povoroznyuk VV, Grygorieva NV, Kanis JA, McCloskey EV, Johansson H. Ukrainian Version of FRAX: from Creation to Validation. Bol', Sustavy, Pozvonochnik. 2016;3(23):5-14. doi: : 10.22141/2224-1507.3.23.2016.85000. (in Ukrainian)

Chen P, Krege JH, Adachi JD. Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res. 2009 Mar;24(3):495-502. doi: 10.1359/jbmr.081103.

Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282(7):637–45. PMID: 10517716.

Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14:821-8. doi: 10.1359/jbmr.1999.14.5.821.

Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE Trial. Bone. 2003;33:522-32. PMID: 14555255.

Pongchaiyakul C, Nguyen ND, Jones G, Center JR, Eisman JA, Nguyen TV. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: A long-term prospective study. J Bone Miner Res. 2005;8:1349-55. doi: 10.1359/JBMR.050317.

Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18(6):761-70. doi: 10.1007/s00198-006-0306-8.

Cauley JA, Hochberg MC, Lui L, et al. Long-term risk of incident vertebral fractures. JAMA. 2007 Dec 19;298(23):2761-7. doi: 10.1001/jama.298.23.2761.

Blank R.D. FRAX(®) Position Development Conference Members. Official Positions for FRAX® clinical regarding prior fractures from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J ClinDensitom. 2011 Jul-Sep;14(3):205-11. doi: 10.1016/j.jocd.2011.05.009.

Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR. FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res. 2009 Nov;24(11):1793-9. doi: 10.1359/jbmr.090511.

So GY, Park KH, Yoon DH, Ryu JH, Choi YS. Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea. Asian Spine J. 2012 Mar;6(1):22-8. doi: 10.4184/asj.2012.6.1.22.

El Maghraoui A1, Sadni S, Jbili N, Rezqi A, Mounach A, Ghozlani I. The discriminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study. BMC Musculoskelet Disord. 2014 Nov 4;15:365. doi: 10.1186/1471-2474-15-365.